Terumo Co. (OTCMKTS:TRUMY) Short Interest Down 16.2% in April

Terumo Co. (OTCMKTS:TRUMY - Get Free Report) was the target of a significant drop in short interest in April. As of April 15th, there was short interest totalling 51,900 shares, a drop of 16.2% from the March 31st total of 61,900 shares. Based on an average trading volume of 616,800 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the company's shares are short sold.

Terumo Stock Down 3.1 %

Shares of OTCMKTS TRUMY traded down $0.62 during mid-day trading on Thursday, reaching $19.10. The company had a trading volume of 78,125 shares, compared to its average volume of 177,320. The stock has a fifty day moving average of $18.74 and a two-hundred day moving average of $19.07. Terumo has a 12-month low of $14.06 and a 12-month high of $21.22. The company has a market capitalization of $28.28 billion, a price-to-earnings ratio of 39.68 and a beta of 0.88. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.70 and a current ratio of 2.94.

Terumo (OTCMKTS:TRUMY - Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The company reported $0.16 EPS for the quarter. The company had revenue of $1.73 billion for the quarter.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.